Cited by 5,699Cardiovascular Function and Risk FactorsBlood Pressure and Hypertension StudiesCardiovascular Effects of Exercise

The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Open access

Levy, Daniel, Garrison, Robert J., Savage, Daniel D., Kannel, William B., Castelli, William P.·1990·New England Journal of Medicine

DOI 10.1056/nejm199005313222203

Open this paper in CoChat — free account Open PDF

Abstract

A pattern of left ventricular hypertrophy evident on the electrocardiogram is a harbinger of morbidity and mortality from cardiovascular disease. Echocardiography permits the noninvasive determination of left ventricular mass and the examination of its role as a precursor of morbidity and mortality. We examined the relation of left ventricular mass to the incidence of cardiovascular disease, mortality from cardiovascular disease, and mortality from all causes in 3220 subjects enrolled in the Framingham Heart Study who were 40 years of age or older and free of clinically apparent cardiovascular disease, in whom left ventricular mass was determined echocardiographically. During a four-year follow-up period, there were 208 incident cardiovascular events, 37 deaths from cardiovascular disease, and 124 deaths from all causes. Left ventricular mass, determined echocardiographically, was associated with all outcome events. This relation persisted after we adjusted for age, diastolic blood pressure, pulse pressure, treatment for hypertension, cigarette smoking, diabetes, obesity, the ratio of total cholesterol to high-density lipoprotein cholesterol, and electrocardiographic evidence of left ventricular hypertrophy. In men, the risk factor-adjusted relative risk of cardiovascular disease was 1.49 for each increment of 50 g per meter in left ventricular mass corrected for the subject's height (95 percent confidence interval, 1.20 to 1.85); in women, it was 1.57 (95 percent confidence interval, 1.20 to 2.04). Left ventricular mass (corrected for height) was also associated with the incidence of death from cardiovascular disease (relative risk, 1.73 [95 percent confidence interval, 1.19 to 2.52] in men and 2.12 [95 percent confidence interval, 1.28 to 3.49] in women). Left ventricular mass (corrected for height) was associated with death from all causes (relative risk, 1.49 [95 percent confidence interval, 1.14 to 1.94] in men and 2.01 [95 percent confidence interval, 1.44 to 2.81] in women). We conclude that the estimation of left ventricular mass by echocardiography offers prognostic information beyond that provided by the evaluation of traditional cardiovascular risk factors. An increase in left ventricular mass predicts a higher incidence of clinical events, including death, attributable to cardiovascular disease.

Integrity signals

Registry

Crossref · 10.1056/nejm199005313222203

Cites

28 of 28 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
Devereux, R. B., Alonso, D. R., Lutas, E. M., Gottlieb, G. J., Campo, E., Sachs, I., & Reichek, N. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90771-x · Cited by 6,226
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.
Devereux, R. B., & Reichek, N. (1977) · Circulation · doi:10.1161/01.cir.55.4.613 · Cited by 4,499
Epidemiological approaches to heart disease: the Framingham study
Dawber, T. R., Meadors, G. F., & Moore, F. E. (1951) · American Journal of Public Health and the Nations Health · doi:10.2105/ajph.41.3.279 · Cited by 2,148
Value of Echocardiographic Measurement of Left Ventricular Mass in Predicting Cardiovascular Morbid Events in Hypertensive Men
Casale, P. N., Devereux, R. B., Milner, M. R., Zullo, G., Harshfield, G. A., Pickering, T. G., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-2-173 · Cited by 1,079
Echocardiographically Detected Left Ventricular Hypertrophy: Prevalence and Risk Factors
Levy, D. A., Anderson, K. M., SAVAGE, D. D., Kannel, W. B., Christiansen, J. C., & Castelli, W. P. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-1-7 · Cited by 819
Echocardiographic criteria for left ventricular hypertrophy: The Framingham heart study
Levy, D. A., Savage, D. D., Garrison, R. J., Anderson, K. M., Kannel, W. B., & Castelli, W. P. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)91133-7 · Cited by 798
Left Ventricular Mass and Incidence of Coronary Heart Disease in an Elderly Cohort
Levy, D. A., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-2-101 · Cited by 700
Electrocardiographic Left Ventricular Hypertrophy and Risk of Coronary Heart Disease
Kannel, W. B., Gordon, T., Castelli, W. P., & MARGOLIS, J. R. (1970) · Annals of Internal Medicine · doi:10.7326/0003-4819-72-6-813 · Cited by 638
Ventricular Arrhythmias in Patients with Hypertensive Left Ventricular Hypertrophy
McLenachan, J. M., Henderson, E., Morris, K. I., & Dargie, H. J. (1987) · New England Journal of Medicine · doi:10.1056/nejm198709243171302 · Cited by 576

Show all 28 references

Research works printed but not linked: 2

Levy, 1987, Circulation, 76, IV-143
Marcus, 1987, Circulation, 75, I-19

Sorted by citations

Items 501–600 of 1,020

MAP kinase‐ and Rho‐dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells
Thorburn, J., Xu, S., & Thorburn, A. M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.8.1888 · Cited by 155
Blockade of the Renin-Angiotensin System in Cardiac Pressure-Overload Hypertrophy in Rats
Bruckschlegel, G., Holmer, S. R., Jandeleit-Dahm, K. A. M., Grimm, D. G., Muders, F., Kromer, E. P., Riegger, G. A. J., & Schunkert, H. (1995) · Hypertension · doi:10.1161/01.hyp.25.2.250 · Cited by 155
Left Ventricular Function in Hypertension: New Insight by Speckle Tracking Echocardiography
Imbalzano, E., Zito, C., Carerj, S., Oreto, G., Mandraffino, G., Cusmà-Piccione, M., Bella, G. D., Saitta, C., & Saitta, A. (2011) · Echocardiography · doi:10.1111/j.1540-8175.2011.01410.x · Cited by 152
Left ventricular hypertrophy associated with chronic cocaine abuse.
Brickner, M. E., Willard, J. E., Eichhorn, E. J., Black, J., & Grayburn, P. A. (1991) · Circulation · doi:10.1161/01.cir.84.3.1130 · Cited by 154
Cardiovascular Consequences of Sleep Apnea
Selim, B. J., Won, C. H. J., & Yaggi, H. K. (2010) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2010.02.010 · Cited by 153
The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) Trial of Cardiovascular Events in Hypertension. Rationale and Design
Mann, S. (1998) · Blood Pressure · doi:10.1080/080370598437394 · Cited by 153
Effect of Obesity on Electrocardiographic Left Ventricular Hypertrophy in Hypertensive Patients
Okin, P. M., Jern, S., Devereux, R. B., Kjeldsen, S. E., Dahlöf, B., & for the LIFE Study Group (2000) · Hypertension · doi:10.1161/01.hyp.35.1.13 · Cited by 152
Secondary prevention with folic acid: effects on clinical outcomes
Liem, A. H., Reynierse-Buitenwerf, G. H., Zwinderman, A. H., Jukema, J. W., & van Veldhuisen, D. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00485-6 · Cited by 150
MicroRNAs in control of cardiac hypertrophy
Martins, P. A. D. C., & Windt, L. J. D. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs013 · Cited by 149
Nutrition in cardiovascular disease: salt in hypertension and heart failure
He, F. J., Burnier, M., & MacGregor, G. A. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr194 · Cited by 153
White Coat Hypertension in Childhood: Evidence for End-Organ Effect
Kavey, R.-E. W., Kveselis, D. A., Atallah, N., & Smith, F. C. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.01.033 · Cited by 150
Clinical and research aspects of ambulatory blood pressure monitoring in children
Lurbe, E., Sorof, J. M., & Daniels, S. R. (2004) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2003.09.050 · Cited by 150
Calcineurin Plays a Critical Role in Pressure Overload–Induced Cardiac Hypertrophy
Shimoyama, M., Hayashi, D., Takimoto, E., Zou, Y., Oka, T., Uozumi, H., Kudoh, S., Shibasaki, F., Yazaki, Y., Nagai, R., et al. (1999) · Circulation · doi:10.1161/01.cir.100.24.2449 · Cited by 150
Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen
Harjai, K. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00009 · Cited by 150
Obesity Promotes Left Ventricular Concentric Rather Than Eccentric Geometric Remodeling and Hypertrophy Independent of Blood Pressure
Woodiwiss, A. J., Libhaber, C. D., Majane, O. H. I., Libhaber, E., Maseko, M. J., & Norton, G. R. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.252 · Cited by 151
Concentric left ventricular hypertrophy brings deterioration of systolic longitudinal, circumferential, and radial myocardial deformation in hypertensive patients with preserved left ventricular pump function
Mizuguchi, Y., Oishi, Y., Miyoshi, H., Íuchi, A., Nagase, N., & Oki, T. (2009) · Journal of Cardiology · doi:10.1016/j.jjcc.2009.07.006 · Cited by 149
Blood Pressure Trajectories From Childhood to Young Adulthood Associated With Cardiovascular Risk
Hao, G., Wang, X., Treiber, F. A., Harshfield, G. A., Kapuku, G. K., & Su, S. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08312 · Cited by 156
A requirement for the rac1 GTPase in the signal transduction pathway leading to cardiac myocyte hypertrophy.
Pracyk, J. B., Tanaka, K., Hegland, D. D., Kim, K. S., Sethi, R., Rovira, I. I., Blazina, D. R., Lee, L., Bruder, J. T., Kovesdi, I., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2552 · Cited by 148
Effect of Immunosuppressive Agents on Long-Term Survival of Renal Transplant Recipients
Boots, J. M. M., Christiaans, M. H. L., & van Hooff, J. P. (2004) · Drugs · doi:10.2165/00003495-200464180-00004 · Cited by 148
Fetal Hemodynamic Adaptive Changes Related to Intrauterine Growth
Verburg, B. O., Jaddoe, V. W. V., Wladimiroff, J. W., Albert Hofman, D., Witteman, J. C. M., & Steegers, E. A. P. (2008) · Circulation · doi:10.1161/circulationaha.107.709717 · Cited by 151
European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts).
Backer, G. D., Ambrosio, G., Borch‐Johnsen, K., Brotons, C., Cífková, R., Dallongeville, J., Ebrahim, S. B. J., Færgeman, O., Graham, I. D., Mancia, G., et al. (2003) · PubMed · doi:10.1097/01.hjr.0000087913.96265.e2 · Cited by 153
Meta-Analysis of Left Ventricular Hypertrophy and Sustained Arrhythmias
Chatterjee, S., Bavishi, C., Sardar, P., Agarwal, V., Krishnamoorthy, P. M., Grodzicki, T. K., & Messerli, F. H. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.07.015 · Cited by 147
Symptomatic Aortic Stenosis
Antonini‐Canterin, F., Huang, G., Cervesato, E., Faggiano, P. M., Pavan, D., Piazza, R., & Nicolosi, G. L. (2003) · Hypertension · doi:10.1161/01.hyp.0000070029.30058.59 · Cited by 148
Effect of Moderate Diet-Induced Weight Loss and Weight Regain on Cardiovascular Structure and Function
Fuentes, L. D. L., Waggoner, A. D., Mohammed, B. S., Stein, R. I., Miller, B. V., Foster, G. D., Wyatt, H. R., Klein, S. B., & Dávila‐Román, V. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.054 · Cited by 146
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
Date, M., Morita, T., Yamashita, N., Nishida, K., Yamaguchi, O., Higuchi, Y., Hirotani, S., Matsumura, Y., Hori, M., Tada, M., et al. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01826-5 · Cited by 147
Angiotensin II Related to Sodium Excretion Modulates Left Ventricular Structure in Human Essential Hypertension
Schmieder, R. E., Langenfeld, M. R. W., Friedrich, A., Schobel, H. P., Gatzka, C. D., & Weihprecht, H. (1996) · Circulation · doi:10.1161/01.cir.94.6.1304 · Cited by 147
Bivariate genetic analysis of left ventricular mass and weight in pubertal twins (the Medical College of Virginia Twin Study)
Verhaaren, H. A., Schieken, R. M., Mosteller, M., Hewitt, J. K., Eaves, L. J., & Nance, W. E. (1991) · The American Journal of Cardiology · doi:10.1016/0002-9149(91)90361-n · Cited by 146
Isoproterenol Activates Extracellular Signal–Regulated Protein Kinases in Cardiomyocytes Through Calcineurin
Zou, Y., Yao, A., Zhu, W., Kudoh, S., Hiroi, Y., Shimoyama, M., Uozumi, H., Kohmoto, O., Takahashi, T., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/hc2601.090987 · Cited by 146
Influence of contemporary versus 30-year blood pressure levels on left ventricular mass and geometry: The Framingham Heart Study
Lauer, M. S., Anderson, K. M., & Levy, D. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90549-o · Cited by 143
QRS Duration and QT Interval Predict Mortality in Hypertensive Patients With Left Ventricular Hypertrophy
Oikarinen, L., Nieminen, M. S., Viitasalo, M. T., Toivonen, L. K., Jern, S., Dahlöf, B., Devereux, R. B., & Okin, P. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000125230.46080.c6 · Cited by 144
Incarceration, Incident Hypertension, and Access to Health Care
Wang, E. A., Pletcher, M. J., Lin, F., Vittinghoff, E., Kertesz, S. G., Kiefe, C. I., & Bibbins-Domingo, K. B. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.26 · Cited by 144
A new method for indexing left ventricular mass for differences in body size
Lauer, M. S., Anderson, K. M., Larson, M. G., & Levy, D. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90909-1 · Cited by 142
Self-citation
The opposing effects of CCN2 and CCN5 on the development of cardiac hypertrophy and fibrosis
Yoon, P. O., Lee, M.-A., Cha, H., Jeong, M. H., Kim, J., Jang, S. P., Choi, B. Y., Jeong, D., Yang, D. K., Hajjar, R. J., et al. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.04.010 · Cited by 143
Prediction of Cardiac Structure and Function by Repeated Clinic and Ambulatory Blood Pressure
Fagard, R. H., Staessen, J. A., & Thijs, L. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.22 · Cited by 143
Creatine kinase–mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved
Gupta, A. K., Akki, A. S., Wang, Y., Leppo, M. K., Chacko, V. P., Foster, D. B., Caceres, V., Shi, S., Kirk, J. A., Su, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57426 · Cited by 141
Left ventricular mass in normotensive, prehypertensive and hypertensive children and adolescents
Stabouli, S., Kotsis, V., Rizos, Z., Toumanidis, S. T., Karagianni, C., Constantopoulos, A., & Zakopoulos, N. A. (2009) · Pediatric Nephrology · doi:10.1007/s00467-009-1165-2 · Cited by 142
Piezo1-Mediated Mechanotransduction Promotes Cardiac Hypertrophy by Impairing Calcium Homeostasis to Activate Calpain/Calcineurin Signaling
Zhang, Y., Su, S., Li, W., Ma, Y., Shen, J., Wang, Y., Shen, Y., Chen, J., Ji, Y., Xie, Y., et al. (2021) · Hypertension · doi:10.1161/hypertensionaha.121.17177 · Cited by 147
Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE study
Wachtell, K., Palmieri, V., Olsen, M. H., Bella, J. N., Aalto, T., Dahlöf, B., Gerdts, E., Wright, J. T., Papademetriou, V., Mogensen, C. E., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.119895 · Cited by 142
Failure of Calcineurin Inhibitors to Prevent Pressure-Overload Left Ventricular Hypertrophy in Rats
Zhang, W., Kowal, R. C., Rusnak, F. M., Sikkink, R. A., Olson, E. N., & Victor, R. G. (1999) · Circulation Research · doi:10.1161/01.res.84.6.722 · Cited by 142
Bioenergetic abnormalities associated with severe left ventricular hypertrophy.
Zhang, J. J., Merkle, H., Hendrich, K. S., Garwood, M., From, A. H. L., Uǧurbil, K., & Bache, R. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116676 · Cited by 142
Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in moderate essential hypertension
Duprez, D. A., Bauwens, F. R., De Buyzere, M. L., De Backer, T. L., Kaufman, J. M., Van Hoecke, J., Vermeulen, A., & Clement, D. L. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)90240-d · Cited by 139
Prognostic value of myocardial circumferential strain for incident heart failure and cardiovascular events in asymptomatic individuals: the Multi-Ethnic Study of Atherosclerosis
Choi, E., Rosen, B. D., Fernandes, V., Yan, R. T., Yoneyama, K., Donekal, S., Opdahl, A., de Almeida, A. L. C., Wu, C. O., Gomes, A. S., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht133 · Cited by 141
Favorable Changes in Cardiac Geometry and Function Following Gastric Bypass Surgery
Owan, T., Avelar, E., Morley, K., Jiji, R. S., Hall, N. L., Krezowski, J. T., Gallagher, J., Williams, Z., Preece, K., Gundersen, N., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.10.017 · Cited by 142
Left ventricular hypertrophy as a predictor of cardiovascular risk
Gosse, P. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000165625.79933.9a · Cited by 141
Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the framingham heart study)
Lauer, M. S., Evans, J. C., & Levy, D. A. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90052-z · Cited by 141
Mechanical Stretch Induces Hypertrophic Responses in Cardiac Myocytes of Angiotensin II Type 1a Receptor Knockout Mice
Kudoh, S., Komuro, I., Hiroi, Y., Zou, Y., Harada, K., Sugaya, T., Takekoshi, N., Murakami, K., Kadowaki, T., & Yazaki, Y. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.24037 · Cited by 141
Left ventricular structure and diastolic function with human ageing Relation to habitual exercise and arterial stiffness
Gates, P. E. (2003) · European Heart Journal · doi:10.1016/j.ehj.2003.09.026 · Cited by 144
Diastolic dysfunction and diastolic heart failure: diagnostic, prognostic and therapeutic aspects
Galderisi, M. (2005) · Cardiovascular Ultrasound · doi:10.1186/1476-7120-3-9 · Cited by 140
Role of the Ubiquitin Proteasome System in the Heart
Pagan, J. K., Seto, T., Pagano, M., & Cittadini, A. (2013) · Circulation Research · doi:10.1161/circresaha.112.300521 · Cited by 143
Sudden Cardiac Death Among Firefighters ≤45 Years of Age in the United States
Yang, J., Teehan, D., Farioli, A., Baur, D. M., Smith, D. L., & Kales, S. N. (2013) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.08.029 · Cited by 148
Prospectively Randomized Evaluation of Stentless Versus Conventional Biological Aortic Valves : Impact on Early Regression of Left Ventricular Hypertrophy
Walther, T., Falk, V., Langebartels, G., Kruger, M., Bernhardt, U., Diegeler, A., Gummert, J. F., Autschbach, R., & Mohr, F. W. (1999) · Circulation · doi:10.1161/01.cir.100.suppl_2.ii-6 · Cited by 139
Gender differences in left ventricle geometry and function in patients undergoing balloon dilatation of the aortic valve for isolated aortic stenosis. NHLBI Balloon Valvuloplasty Registry.
Douglas, P. S., Otto, C. M., Mickel, M. C., Labovitz, A. J., Reid, C. L., & Davis, K. B. (1995) · Heart · doi:10.1136/hrt.73.6.548 · Cited by 138
Prevention of Cardiac Hypertrophy and Heart Failure by Silencing of NF-κB
Gupta, S., Young, D., Maitra, R. K., Gupta, A. D., Popović, Z., Yong, S. L., Mahajan, A., Wang, Q. K., & Sen, S. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.10.006 · Cited by 138
The epidemiology of left ventricular hypertrophy in type 2 diabetes mellitus
Dawson, A., Morris, A. D., & Struthers, A. D. (2005) · Diabetologia · doi:10.1007/s00125-005-1896-y · Cited by 137
Normal values of left ventricular mass and cardiac chamber volumes assessed by 320-detector computed tomography angiography in the Copenhagen General Population Study
Fuchs, A., Mejdahl, M., Kühl, J. T., Stisen, Z. R., Nilsson, E. J. P., Køber, L., Nordestgaard, B. G., & Kofoed, K. F. (2016) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jev337 · Cited by 137
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy
Ibsen, H., Wachtell, K., Olsen, M. H., Borch‐Johnsen, K., Lindholm, L. H., Mogensen, C. E., Dahl??f, B., Devereux, R. B., Fairé, U. D., Fyhrquist, F., et al. (2004) · Journal of Hypertension · doi:10.1097/00004872-200409000-00026 · Cited by 137
Regression of Radial Artery Wall Hypertrophy and Improvement of Carotid Artery Compliance After Long-Term Antihypertensive Treatment in Elderly Patients 11This study was supported by grants from the Institut National de la Santé et de la Recherche Médicale (INSERM) (Grant 494014), Paris; Laboratoires SERVIER; and the European Community (BIOMED), Brussels, Belgium.
Girerd, X. J., Giannattasio, C., Moulin, C., Safar, M. E., Mancia, G., & Laurent, S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00043-6 · Cited by 137
Aortic valve replacement with stentless and stented porcine valves: a case-match study
David, T. E., Puschmann, R., Ivanov, J., Bos, J., Armstrong, S. M., Feindel, C. M., & Scully, H. E. (1998) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70122-9 · Cited by 137
Hypoxia-Inducible Factor-1: A Critical Player in the Survival Strategy of Stressed Cells
Chen, S., & Sang, N. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25283 · Cited by 137
The regulatory roles of p53 in cardiovascular health and disease
Men, H., Cai, H., Cheng, Q., Zhou, W., Wang, X., Huang, S., Zheng, Y., & Cai, L. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03694-6 · Cited by 137
Dyslipidemia and an Unfavorable Fatty Acid Profile Predict Left Ventricular Hypertrophy 20 Years Later
Sundström, J., Lind, L., Vessby, B. O., Andrén, B., Aro, A., & Lithell, H. (2001) · Circulation · doi:10.1161/01.cir.103.6.836 · Cited by 136
Microarray analysis reveals pivotal divergent mRNA expression profiles early in the development of either compensated ventricular hypertrophy or heart failure
Buermans, H. P. J., Redout, E. M., Schiel, A. E., Musters, R. J. P., Zuidwijk, M. J., Eijk, P. P., van Hardeveld, C., Kasanmoentalib, S., Visser, F. C., Ylstra, B., et al. (2005) · Physiological Genomics · doi:10.1152/physiolgenomics.00185.2004 · Cited by 136
Molecular mechanism of cardiac cellular hypertrophy by mechanical stress
YAMAZAKI, T., Komuro, I., & Yazaki, Y. (1995) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(08)80013-2 · Cited by 136
Masked nocturnal hypertension—a novel marker of risk in type 2 diabetes
Wijkman, M. O., Länne, T., Engvall, J. E., Lindström, T., Östgren, C. J., & Nyström, F. H. (2009) · Diabetologia · doi:10.1007/s00125-009-1369-9 · Cited by 135
Multi-Tasking RGS Proteins in the Heart
Riddle, E. L., Schwartzman, R. A., Bond, M., & Insel, P. A. (2005) · Circulation Research · doi:10.1161/01.res.0000158287.49872.4e · Cited by 135
Cardiac Overexpression of a G q Inhibitor Blocks Induction of Extracellular Signal–Regulated Kinase and c-Jun NH 2 -Terminal Kinase Activity in In Vivo Pressure Overload
Esposito, G., Prasad, S. V. N., Rapacciuolo, A., Mao, L., Koch, W. J., & Rockman, H. A. (2001) · Circulation · doi:10.1161/01.cir.103.10.1453 · Cited by 135
Augmentation of Central Arterial Pressure in Mild Primary Hyperparathyroidism
Smith, J. C., Page, M. D., John, R., Wheeler, M. H., Cockcroft, J. R., Scanlon, M. F., & Davies, J. S. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6880 · Cited by 134
Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo
Lu, F. Y., Moore, X., Gao, X., Dart, A. M., Lim, Y. L., & Du, X. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.04.003 · Cited by 135
Long-term effects of amlodipine and lisinopril on left ventricular mass and diastolic function in elderly, previously untreated hypertensive patients: the ELVERA trial
Terpstra, W. F., May, J. F., Smit, A. J., de Graeff, P. A., Havinga, T. K., van der Veur, E., Schuurman, F. H., Jong, B. M., & Crijns, H. J. G. M. (2001) · Journal of Hypertension · doi:10.1097/00004872-200102000-00018 · Cited by 135
Cardiac myocyte follistatin-like 1 functions to attenuate hypertrophy following pressure overload
Shimano, M., Ouchi, N., Nakamura, K., van Wijk, B., Ohashi, K., Asaumi, Y., Higuchi, A., Pimentel, D. R., Sam, F., Murohara, T., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108559108 · Cited by 136
Low serum magnesium concentrations predict cardiovascular and all-cause mortality
Reffelmann, T., Ittermann, T., Dörr, M., Völzke, H., Reinthaler, M., Petersmann, A., & Felix, S. B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.05.038 · Cited by 134
Role of Aldosterone in Left Ventricular Hypertrophy in Hypertension
Matsumura, K., FUJII, K., Oniki, H., Oka, M., & Iida, M. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.013 · Cited by 134
Modeling relationships among socioeconomic status, hostility, cardiovascular reactivity, and left ventricular mass in African American and White children.
Gump, B. B., Matthews, K. A., & Räikkönen, K. (1999) · Health Psychology · doi:10.1037//0278-6133.18.2.140 · Cited by 134
Calcineurin Plays a Critical Role in the Development of Pressure Overload–Induced Cardiac Hypertrophy
Zou, Y., Hiroi, Y., Uozumi, H., Takimoto, E., Toko, H., Zhu, W., Kudoh, S., Mizukami, M., Shimoyama, M., Shibasaki, F., et al. (2001) · Circulation · doi:10.1161/01.cir.104.1.97 · Cited by 134
MicroRNAs as a therapeutic target for cardiovascular diseases
Mishra, P. K., Tyagi, N., Kumar, M., & Tyagi, S. C. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00744.x · Cited by 134
The Wnt/β-Catenin Signaling Pathway as a Target in Drug Discovery
Takahashi‐Yanaga, F., & Sasaguri, T. (2007) · Journal of Pharmacological Sciences · doi:10.1254/jphs.cr0070024 · Cited by 137
Correlates of global area strain in native hypertensive patients: a three-dimensional speckle-tracking echocardiography study
Galderisi, M., Esposito, R., Schiano-Lomoriello, V., Santoro, A., Ippolito, R., Schiattarella, P. L., Strazzullo, P., & SIMONE, G. D. (2012) · European Heart Journal - Cardiovascular Imaging · doi:10.1093/ehjci/jes026 · Cited by 133
The Angiotensin II Type 2 Receptor Causes Constitutive Growth of Cardiomyocytes and Does Not Antagonize Angiotensin II Type 1 Receptor–Mediated Hypertrophy
D’Amore, A., Black, M. J., & Thomas, W. G. (2005) · Hypertension · doi:10.1161/01.hyp.0000193504.51489.cf · Cited by 133
Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?
Hankey, G. J., Slattery, J., & Warlow, C. P. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.640 · Cited by 133
Left Ventricular Mass and Geometry and the Risk of Ischemic Stroke
Tullio, M. R. D., Zwas, D. R., Sacco, R. L., Sciacca, R. R., & Homma, S. (2003) · Stroke · doi:10.1161/01.str.0000089680.77236.60 · Cited by 132
Cardiac histone acetylation – therapeutic opportunities abound
McKinsey, T. A., & Olson, E. N. (2004) · Trends in Genetics · doi:10.1016/j.tig.2004.02.002 · Cited by 131
Disparate effects of left ventricular geometry and obesity on mortality in patients with preserved left ventricular ejection fraction
Lavie, C. J., Milani, R. V., Ventura, H. O., Cardenas, G. A., Mehra, M. R., & Messerli, F. H. (2007) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.06.040 · Cited by 131
Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'?
Lip, G. Y. H. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2339 · Cited by 128
Norepinephrine Induces the raf -1 Kinase/Mitogen-Activated Protein Kinase Cascade Through Both α 1 - and β-Adrenoceptors
Yamazaki, T., Komuro, I., Zou, Y., Kudoh, S., Shiojima, I., Hiroi, Y., Mizuno, T., Aikawa, R., Takano, H., & Yazaki, Y. (1997) · Circulation · doi:10.1161/01.cir.95.5.1260 · Cited by 130
Hypertension in Aortic Stenosis: Implications for Left Ventricular Structure and Cardiovascular Events
Rieck, Å. E., Cramariuc, D., Boman, K., Gohlke-Bärwolf, C., Staal, E. M., Lønnebakken, M. T., Rossebø, A. B., & Gerdts, E. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.194878 · Cited by 129
Association of Obesity and Hypertension With Left Ventricular Geometry and Function in Children and Adolescents
Dhuper, S., Abdullah, R. A., Weichbrod, L., Mahdi, E. S., & Cohen, H. W. (2010) · Obesity · doi:10.1038/oby.2010.134 · Cited by 127
Genetic Influences in Sport and Physical Performance
Puthucheary, Z., Skipworth, J. R. A., Rawal, J., Loosemore, M., van Someren, K. A., & Montgomery, H. (2011) · Sports Medicine · doi:10.2165/11593200-000000000-00000 · Cited by 131
Attenuation of cardiac fibrosis by pirfenidone and amiloride in DOCA‐salt hypertensive rats
Mirkovic, S., Seymour, A. L., Fenning, A. S., Strachan, A. J., Margolin, S. B., Taylor, S. M., & Brown, L. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704539 · Cited by 129
Operator Induced Variability in Left Ventricular Measurements with Cardiovascular Magnetic Resonance is Improved After Training
Karamitsos, T. D., Hudsmith, L., Selvanayagam, J. B., Neubauer, S., & Francis, J. M. (2007) · Journal of Cardiovascular Magnetic Resonance · doi:10.1080/10976640701545073 · Cited by 128
Kidney in Hypertension
Coffman, T. M., & Crowley, S. D. (2008) · Hypertension · doi:10.1161/hypertensionaha.105.063636 · Cited by 127
MicroRNA: A new therapeutic strategy for cardiovascular diseases
Samanta, S., Balasubramanian, S., Rajasingh, S., Patel, U., Dhanasekaran, A., Dawn, B., & Rajasingh, J. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.004 · Cited by 128
Left Ventricular Hypertrophy Regression During Antihypertensive Treatment in an Outpatient Clinic (the Campania Salute Network)
Lønnebakken, M. T., Izzo, R., Mancusi, C., Gerdts, E., Losi, M. A., Canciello, G., Giugliano, G., LUCA, N. D., Trimarco, B., & SIMONE, G. D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.004152 · Cited by 127
Nuclear Factor-κB Activation Leads to Down-regulation of Fatty Acid Oxidation during Cardiac Hypertrophy
Planavila, A., Laguna, J. C., & Vázquez‐Carrera, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414220200 · Cited by 127
Into the heart: The emerging role of the ubiquitin–proteasome system
Willis, M. S., & Patterson, C. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.07.015 · Cited by 125
Activation of nuclear factor-κB is necessary for myotrophin-induced cardiac hypertrophy
Gupta, S., Purcell, N. H., Lin, A., & Sen, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200207149 · Cited by 127
Nocturnal non-dipping: what does it augur?
Pickering, T. G., & Kario, K. (2001) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200109000-00010 · Cited by 128
Superinhibition of Sarcoplasmic Reticulum Function by Phospholamban Induces Cardiac Contractile Failure
Haghighi, K., Schmidt, A. G., Hoit, B. D., Brittsan, A. G., Yatani, A., Lester, J. W., Zhai, J., Kimura, Y., Dorn, G. W., MacLennan, D. H., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102403200 · Cited by 127
Left Ventricular Mass in Diabetes-Hypertension
Grossman, E. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400170085016 · Cited by 126
Transforming Growth Factor β in Hypertensives With Cardiorenal Damage
Laviades, C., Varo, N., & Dı́ez, J. (2000) · Hypertension · doi:10.1161/01.hyp.36.4.517 · Cited by 126
Mouse SIRT3 Attenuates Hypertrophy-Related Lipid Accumulation in the Heart through the Deacetylation of LCAD
Chen, T., Liu, J., Li, N., Wang, S., Liu, H., Li, J., Zhang, Y., & Bu, P. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118909 · Cited by 125

Authors: Levy, D., Garrison, R. J., Savage, D. D., Kannel, W. B., & Castelli, W. P.
Affiliations: National Heart, Lung, and Blood Institute (US)
National Center for Health Statistics (US)
Boston University (US)
ORCID: Levy, Daniel
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1990-05-31
Volume: 322
Issue: 22
Pages: 1561-1566
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199005313222203
OpenAlex: W2334499091
Cited by: 5,699
References: 28
Citations by year: 2026: 77 · 2025: 76 · 2024: 85 · 2023: 100 · 2022: 117 · 2021: 124 · 2020: 156 · 2019: 142 · 2018: 134 · 2017: 170 · 2016: 189 · 2015: 211 · 2014: 215 · 2013: 199 · 2012: 215
FWCI: 76.54
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Keywords: left ventricular mass, left ventricular hypertrophy, cardiovascular disease incidence, cardiovascular mortality, all-cause mortality, echocardiography, cardiovascular risk factors, hypertension, sex differences, Framingham Heart Study
MeSH terms: Blood Pressure, Echocardiography, Female, Follow-Up Studies, Cardiomegaly, Humans, Lipids, Male, Middle Aged, Prognosis, Risk Factors, Smoking, Multivariate Analysis, Diabetes Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prognostic Implications of Echocardiographically Determined Left Ventricular Mass in the Framingham Heart Study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks